logo

For the Inventor, By the Inventor

Madrid, Spain

Ana Maria Escribano

This inventor holds 12 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Eli Lilly and Company. Active years: 2001-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ana Maria Escribano. Retrieved from https://idiyas.com/inventor/ana-maria-escribano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 33.3

 

Average Co-Inventor Count = 6.3

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • Alcobendas-Madrid, ES (2010)
  • Alcobendas, ES (2010)
  • Madrid, ES (2001 - 2018)

Company Filing History:

goldMedal12 out of 4,517 
 
Eli Lilly and Company
 patents

Years Active: 2001-2018

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 10053429 - DGAT2 inhibitors (2018-08-21),
2. 8778984 - Aldosterone synthase inhibitor (2014-07-15),
3. 7749992 - Compounds and methods for treating dislipidemia (2010-07-06),
4. 7642361 - Thiophene and furan compounds (2010-01-05),
5. 7470705 - Compounds and methods for treating dyslipidemia (2008-12-30),
6. 7205313 - Excitatory amino acid receptor antagonists (2007-04-17),
7. 7135487 - Sulphonamide derivatives (2006-11-14),
8. 6924294 - Excitatory amino acid receptor antagonists (2005-08-02),
9. 6362230 - Sulphonamide derivatives (2002-03-26),
10. 6355655 - Heterocyclic sulphonamide derivatives (2002-03-12),
11. 6303816 - Sulphonamide derivatives (2001-10-16),
12. 6174922 - Sulphonamide derivatives (2001-01-16),

Title: Trailblazer in Innovation and Sustainability: The Extraordinary Journey of Ana Maria Escribano

Introduction:

Ana Maria Escribano, a visionary inventor from Madrid, ES, stands as a beacon of innovation and sustainability in the realm of technology. With a passion for creating a greener planet, she has become a trailblazer whose work continues to inspire generations of inventors and entrepreneurs.

Latest Patents:

Ana Maria Escribano has made significant contributions to the field of healthcare with her latest patents. One of her groundbreaking inventions includes DGAT2 inhibitors, compounds aimed at treating patients with hypertriglyceridemia and cardiovascular diseases such as dyslipidemia and atherosclerosis. Additionally, her invention of aldosterone synthase inhibitors offers new possibilities for treating various conditions related to aldosterone regulation.

Career Highlights:

Currently affiliated with Eli Lilly and Company, Ana Maria Escribano has accumulated an impressive portfolio of 12 patents throughout her career. Her dedication to pushing the boundaries of innovation in healthcare has led to life-changing advancements in the field.

Collaborations:

In her journey towards innovation, Ana Maria Escribano has had the privilege of collaborating with esteemed professionals in the industry. Notable coworkers include Paul Leslie Ornstein and Dennis Michael Zimmerman, whose collective expertise has enriched the development process of her inventions.

Conclusion:

Ana Maria Escribano's relentless pursuit of innovation and sustainability has not only positioned her as a prominent figure in the world of technology but has also paved the way for a brighter and more eco-conscious future. Her inventive spirit serves as a testament to the transformative power of creativity and dedication in shaping a better world for all.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…